Document is current
Any future updates will be listed below
-
Authors
Jahagirdar, Sanjeevan https://orcid.org/0000-0003-2213-4360
Morris, Lorna
Benis, Nirupama
Oppegaard, Oddvar
Svenson, Mattias
Hyldegaard, Ole
Skrede, Steinar
Norrby-Teglund, Anna
,
Bruun, Trond
Rath, Eivind
Nedrebø, Torbjørn
Arnell, Per
Rosen, Anders
Hedetoft, Morten
Madsen, Martin B.
Svensson, Mattias
Snäll, Johanna
Karlsson, Ylva
Nekludov, Michael
Martins dos Santos, Vitor A. P.
Saccenti, Edoardo https://orcid.org/0000-0001-8284-4829
-
Funding
Funding for this research was provided by:
CIMED (20180058)
FP7 Health (305340, INFECT)
VINNOVA (90456, PerAID)
Innovationsfonden (90456, PerAID & 2018-151, PerMIT, 8113-000009B & 8114-000005B)
Research Council of Norway (90456, PerAID & 2018-151, PerMIT)
ZonMw (2018-151, PerMIT)
Swedish Children's Cancer Foundation (TJ2018-0128)
Vetenskapsrådet (2018-02475 & 2018-151, PerMIT)
- License Information
-
More Information
Article History
Received: 8 December 2021
Accepted: 28 March 2022
First Online: 4 May 2022
Declarations
:
: The INFECT study was conducted in accordance with the Declaration of Helsinki and with the approval of the regional Ethical Review Board at the Karolinska Institutet in Stockholm. Sweden (Ethics permits: 2012/2110-31/2), the National Committee on Health Research Ethics in Copenhagen, Denmark (Ethics permits: 1151739), the regional Ethical Review Board in Gothenburg, Sweden (Ethics permits: 930-12) and Bergen, Norway (2012/2227/REC West). Specimens from patients admitted to five Scandinavian hospitals, Righospitalet (Copenhagen, Denmark), Karolinska University Hospital (Stockholm, Sweden), Blekingesjukhuset (Karlskrona, Sweden), Sahlgrenska University Hospital (Gothenburg, Sweden) and Haukeland University Hospital (Bergen, Norway), were included in this study.
: Written informed consent was obtained from all patients or their surrogate. The INFECT study is registered at(NCT01790698).
: The authors declare that they have no competing interests.
